| Estimating the burden of SARS-CoV-2 in France H Salje, C Tran Kiem, N Lefrancq, N Courtejoie, P Bosetti, J Paireau, ... Science 369 (6500), 208-211, 2020 | 1200 | 2020 |
| World report on hearing World Health Organization World Health Organization, 2021 | 726 | 2021 |
| Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global … RK Gupta, MR Jordan, BJ Sultan, A Hill, DHJ Davis, J Gregson, ... The Lancet 380 (9849), 1250-1258, 2012 | 464 | 2012 |
| Confirmation of putative HIV-1 group P in Cameroon A Vallari, V Holzmayer, B Harris, J Yamaguchi, C Ngansop, F Makamche, ... Journal of virology 85 (3), 1403-1407, 2011 | 363 | 2011 |
| HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study RL Hamers, CL Wallis, C Kityo, M Siwale, K Mandaliya, F Conradie, ... The Lancet infectious diseases 11 (10), 750-759, 2011 | 343 | 2011 |
| Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 333 | 2019 |
| Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial S Jaffar, B Amuron, S Foster, J Birungi, J Levin, G Namara, C Nabiryo, ... The Lancet 374 (9707), 2080-2089, 2009 | 303 | 2009 |
| Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ... PLoS medicine 12 (4), e1001810, 2015 | 282 | 2015 |
| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ... The Lancet infectious diseases 16 (5), 565-575, 2016 | 279 | 2016 |
| A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon F Kurbanov, Y Tanaka, K Fujiwara, F Sugauchi, D Mbanya, L Zekeng, ... Journal of general Virology 86 (7), 2047-2056, 2005 | 247 | 2005 |
| Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a … RL Hamers, R Schuurman, KCE Sigaloff, CL Wallis, C Kityo, M Siwale, ... The Lancet infectious diseases 12 (4), 307-317, 2012 | 232 | 2012 |
| Update on HIV-1 diversity in Africa: a decade in review RW Lihana, D Ssemwanga, A Abimiku, N Ndembi Aids Rev 14 (2), 83-100, 2012 | 203 | 2012 |
| Consensus and ancestral state HIV vaccines DC Nickle, MA Jensen, GS Gottlieb, D Shriner, GH Learn, AG Rodrigo, ... Science 299 (5612), 1515-1518, 2003 | 181 | 2003 |
| Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa MA Price, CL Wallis, S Lakhi, E Karita, A Kamali, O Anzala, EJ Sanders, ... AIDS research and human retroviruses 27 (1), 5-12, 2011 | 152 | 2011 |
| Four new HIV-1 group N isolates from Cameroon: Prevalence continues to be low A Vallari, P Bodelle, C Ngansop, F Makamche, N Ndembi, D Mbanya, ... AIDS research and human retroviruses 26 (1), 109-115, 2010 | 141 | 2010 |
| Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance X Deng, A Achari, S Federman, G Yu, S Somasekar, I Bártolo, S Yagi, ... Nature microbiology 5 (3), 443-454, 2020 | 132 | 2020 |
| COVID-19 vaccines: how to ensure Africa has access JN Nkengasong, N Ndembi, A Tshangela, T Raji Nature 586 (7828), 197-199, 2020 | 113 | 2020 |
| Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania H Nuwagaba-Biribonwoha, B Werq-Semo, A Abdallah, A Cunningham, ... BMC pediatrics 10, 1-10, 2010 | 108 | 2010 |
| A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide C Wassner, N Bradley, Y Lee Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2020 | 107 | 2020 |
| Global action plan on HIV drug resistance 2017–2021 World Health Organization World Health Organization, 2017 | 106 | 2017 |
